In the United States announced the start of trials of a new treatment for COVID-19
The US National Institutes of Health announced the beginning of clinical trials of a potential treatment for COVID-19 based on so-called monoclonal antibodies. Writes about it "Voice of America".
There are already two known drugs, remdesivir and dexamethasone, which have already shown their effectiveness in treating patients with severe COVID-19. But it may be the first drug to help patients in the early stages of the disease.
“We are now trying to determine what will work in the early stages,” said the head of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci.
Monoclonal antibodies are created in the laboratory and mimic the body's natural antibodies. Antibodies recognize specific pathogens, in this case the SARS-CoV-2 virus that causes COVID-19, and engage the immune system in the fight against them.
The National Institutes of Health tests will use a monoclonal antibody made by the pharmaceutical company Eli Lilly and dubbed LY-CoV555.
Fauci said the antibody was isolated from a COVID-19 patient in Washington state in the early months of the pandemic.
stdClass Object ([term_id] => 12 [name] => In the US [taxonomy] => category [slug] => novosti-ssha)In the U.S.
stdClass Object ([term_id] => 1375 [name] => treatment [taxonomy] => post_tag [slug] => lechenie)treatment
stdClass Object ([term_id] => 28340 [name] => coronavirus [taxonomy] => post_tag [slug] => koronavirus)coronavirus
stdClass Object ([term_id] => 28347 [name] => Special projects [taxonomy] => category [slug] => specproekty)Special Projects
Read also on ForumDaily:
Let's face the crisis together and support each other
Thank you for staying with us and trusting! Over the past 5 years, we have received a lot of grateful feedback from readers, whom our materials have helped to arrange life after moving to the USA. We have big plans, we don't want to stop or slow down the pace of work. Even now…
The COVID-19 pandemic has negatively affected our income, and in order to stay afloat, we have to ask YOU for support. We will be grateful for any amount and will make every effort to continue to publish news and a lot of useful information just as quickly.
Thank you for being with us!
Always yours, ForumDaily! WomanForumDaily, NewYork, ForumDaily!
Security of contributions is guaranteed by the use of the highly secure Stripe system.
Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the "Display Priority" option and read us first. And don't forget to subscribe to ForumDaily Woman and ForumDaily New York - there you will find a lot of interesting and positive information.